Aquilo Capital Management »

Galapagos Nv- shares owned by Aquilo Capital Management

Quarter-by-quarter ownership of Galapagos Nv- (GLPG) shares owned by Aquilo Capital Management from 13F filings

Historical chart of Aquilo Capital Management investment in Galapagos Nv-

Tip: Access up to 7 years of quarterly data

All positions including Galapagos Nv- held by Aquilo Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Galapagos Nv- by Aquilo Capital Management

Quarter filed Position value Share count Share price at filing
2018-09-30 $3.5M 31k 112.42
2018-06-30 $6.1M 66k 92.17

More positions owned by Aquilo Capital Management

SPDR S&P Biotech (XBI)
Merus N V (MRUS)
Loxo Oncology
Fate Therapeutics (FATE)
Aduro Biotech
Synlogic
Cytomx Therapeutics (CTMX)
Pieris Pharmaceuticals (PIRS)
Spero Therapeutics (SPRO)
Xenon Pharmaceuticals (XENE)
Galapagos Nv- (GLPG)
Morphosys (MOR)

View all positions for Aquilo Capital Management

Top funds holding Galapagos Nv-

EcoR1 Capital
FMR
BVF
Deerfield Management Company
Prosight Management
Segall Bryant & Hamill
PRIMECAP Management Company
BlackRock
Finepoint Capital
Wellington Management Company
Hudson Bay Capital Management
Newtyn Management
Millennium Management
Greenlight Capital
DME Capital Management

View all funds holding Galapagos Nv-